Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Jun 2007 for KERYX BIOPHARMACEUTICALS INC, €8,194.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Beth F. Levine: trading record in brief
Beth F. Levine has a single filing on record, published on 20 June 2007: an open-market purchase of €8,194 in Keryx Biopharmaceuticals Inc. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Beth F. Levine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 1,000 shares@ US$11.00Common StockSEC:0001144204-07-032845:0Canonical exit: 16 Sept 2007 (T+90)
1 of 1 declaration
